Cellectar plans Phase III start in late Q4 2026 as it outlines potential WM approval in the second half of 2027

CoreWeave’s AI bonds tumble, raising red flags for the wider market

10/14/2026

Stellus Capital Investment declares $0.0833 dividend

10/14/2026

Lakefront sells early-stage CAR-T programs to Armed Cell Therapeutics

10/14/2026

MSC Industrial Direct raises dividend to $0.89, up 2.3%

10/14/2026